Product List     API & Intermediate     

Antibiotics

Find
156
related chemicals for you
CAS:13412-64-1
Molecular Formula:C19H18Cl2N3NaO6S
Dicloxacillin Sodium Salt Monohydrate; Dicloxacillin Sodium; 3-(2,6-Dichlorophenyl)-5-Methyl-4-Isoxazolyl Penicillin; Dicloxacillin Sodium Salt Hydrate Vetran; Dicloxacillin Monohydrate Sodium Salt; Sodium 7-[3-(2,6-Dichlorophenyl)-5-Methyl-Oxazol-4-Yl]Carbonylamino-3,3-Dimet Hyl-6-Oxo-2-Thia-5-Azabicyclo[3.2.0]Heptane-4-Carboxylate
Brief Introduction
Antibiotics are used for the infection of Staphylococcus aureus resistant to penicillin G.
CAS:1404-04-2
Molecular Formula:C23H52N6O25S3
Brief Introduction
Broad spectrum antibiotics, the antibacterial spectrum is similar to kanamycin. It is mainly used locally to treat various skin and ear infections caused by sensitive bacteria such as Staphylococcus aureus and Proteus.
CAS:18323-44-9
Molecular Formula:C18H33ClN2O5S
CLDM; Clinimycin; Sobelin; 7-Cdl; Dalacinc; Chlolincocin; Dalacine; (2S,4R)-N-((1S,2S)-2-Chloro-1-((2R,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-(Methylthio)Tetrahydro-2H-Pyran-2-yl)Propyl)-1-Methyl-4-Propylpyrrolidine-2-Carboxamide
Brief Introduction
Clindamycin is a derivative of lincomycin. It has good antibacterial effect on all kinds of anaerobic bacteria. It is suitable for the treatment of respiratory system infection, urinary system infection, female pelvic and genital infection, skin and soft tissue infection, bone and joint infection, intra-abdominal infection caused by Gram-positive bacteria and anaerobic bacteria.
CAS:192564-14-0
Molecular Formula:C86H103Cl3N10O34P2
Orbactiv; LY333328 Diphosphate; Oritavancin Phosphate; Oritavancin (Diphosphate); Kimyrsa; Nuvocid; Oritavancin Bisphosphate; (4''R)-22-O-(3-Amino-2,3,6-Trideoxy-3-C-Methyl-Alpha-L-Arabino-Hexopyranosyl)-N(3'')-((4'-Chloro(1,1'-Biphenyl)-4-yl)Methyl)Vancomycin Phosphate(1:2); (4''R)-22-O-(3-Amino-2,3,6-Trideoxy-3-C-Methyl-Alpha-L-Arabino-Hexopyranosyl)-N(sup 3'')-((4'-Chloro(1,1'-Biphenyl)-4-yl)Methyl)Vancomycin Phosphate(1:2) (salt); (4'R)-22-O-(3-Amino-2,3,6-Trideoxy-3-C-Methyl-Alpha-L-Arabino-Hexopyranosyl)-N(sup 3)'-((4'-Chloro(1,1'-Biphenyl)-4-yl)Methyl)Vancomycin Phosphate (1:2) (salt); (4'R)-22-O-(3-Amino-2,3,6-Trideoxy-3-C-Methyl-Alpha-L-Arabino-Hexopyranosyl)-N(sup 3)'-(p-(p-Chlorophenyl)Benzyl)Vancomycin Phosphate (1:2) (salt); (4R)-22-O-(3-Amino-2,3,6-Trideoxy-3-C-Methyl-Alpha-L-Arabinohexopyranosyl)-N3-(p-(p-Chlorophenyl)Benzyl)Vancomycin Diphosphate; Vancomycin, 22-O-(3-Amino-2,3,6-Trideoxy-3-C-Methyl-.Alpha.-L-Arabino-Hexopyranosyl)-N3''-((4'-Chloro(1,1'-Biphenyl)-4-YL)Methyl)-, (4''R)-, Phosphate (1:2)
Brief Introduction
Oritavancin diphosphate is a new semi-synthetic glycopeptide antibiotic that can be used to treat Gram-positive bacterial infections.
CAS:194804-75-6
Molecular Formula:C23H20F2N2O4
Ganefloxacin; T-3811; Garenfloxacin; (R)-1-Cyclopropyl-8-(Difluoromethoxy)-7-(1-Methylisoindolin-5-yl)-4-oxo-1,4-Dihydroquinoline-3-Carboxylic acid; 1-Cyclopropyl-8-(Difluoromethoxy)-7-[(1R)-1-Methyl-2,3-Dihydro-1H-Isoindol-5-yl]-4-Oxoquinoline-3-Carboxylic acid; 1-Cyclopropyl-8-(Difluoromethoxy)-7-[(1R)-1-Methyl-2,3-Dihydro-1H-Isoindol-5-yl]-4-oxo-1,4-Dihydroquinoline-3-Carboxylic acid; Garenoxacine; Garenoxacino; Garenoxacinum; 1-Cyclopropyl-8-(Difluoromethoxy)-7-[(1R)-(1-Methyl-2,3-Dihydro-1H-5-Isoindolyl)-4-oxo-1,4-Dihydro-3-Quinolinecarboxylic acid; 1-Cyclopropyl-8-(Difluoromethoxy)-7-[(1R)-1-Methylisoindolin-5-yl]-4-oxo-Quinoline-3-Carboxylic acid; 1-Cyclopropyl-8-(Difluoromethoxy)-7-[(1R)-2,3-Dihydro-1-Methyl-1H-Isoindol-5-yl]-1,4-Dihydro-4-oxo-3-Quinolinecarboxylic Acid; (R)-1-Cyclopropyl-8-Difluoromethoxy-7-(1-Methyl-2, 3-Dihydro-1H-5-Isoindolyl)-4-oxo-1, 4-Dihydro-3-Quinolinecarboxylic acid; (R)-1-Cyclopropyl-8-Difluoromethoxy-7-(1-Methyl-2,3-Dihydro-1H-5-Isoindolyl)-4-oxo-1,4-Dihydro-3-Quinoline-Carboxylic acid; (R)-1-Cyclopropyl-8-Difluoromethoxy-7-(1-Methyl-2,3-Dihydro-1H-5-Isoindolyl)-4-oxo-1,4-Dihydro-3-Quinolinecarboxylic acid
Brief Introduction
It is a quinolone antibiotic that can treat Gram positive and negative bacterial infections.
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >